Abstract-The stimulation of endothelium-dependent NO release by angiotensin-(1-7) ] has been indirectly shown in terms of vasodilation, which was diminished by NO synthase inhibition or removal of the endothelium. However, direct measurement of endothelium-derived NO has not been analyzed. With a selective porphyrinic microsensor, NO release was directly assessed from single primary cultured bovine aortic endothelial cells. Ang-(1-7) caused a concentration-dependent release of NO of 1 to 10 mol/L, which was attenuated by NO synthase inhibition.
T
here is increasing experimental evidence that in addition to the known effector hormone angiotensin (Ang) II, the heptapeptide Ang-(1-7) is also a biologically active component of the renin-angiotensin system. [1] [2] [3] Besides circulating Ang-(1-7), local production of the heptapeptide has been shown in the vasculature, where it is predominantly generated from Ang I by metalloendopeptidase 24.15. 4 In endothelial cells from different sources, Ang-(1-7) is derived from carboxyl-terminal degradations of Ang I and Ang II by neutral endopeptidase (NEP 24.11) or by carboxypeptidases, respectively. 5 In contrast to Ang II, Ang-(1-7) is neither dipsogen nor an aldosterone secretagogue, but similar to Ang II, it releases vasopressin, 6 prostaglandins, 7 and NO. 8, 9 Also unlike Ang II, Ang-(1-7) inhibits vascular smooth muscle cell growth. 10, 11 In the past years, some studies have indicated that Ang-(1-7) counterregulates the cardiovascular actions of Ang II by acting as a local modulator of the vascular tone. 12 Ang-(1-7) is a vasodilatory agent in many vascular beds, including canine 13 and porcine 14 coronary arteries, rat aorta, 15 and feline mesenteric arteries. 16 Recently, it was demonstrated that Ang-(1-7) blocks the Ang II-induced vasoconstriction in human arteries. 17 Long-term infusion of Ang-(1-7) in spontaneously hypertensive rats (SHR) produced a transient decrease in the mean arterial pressure, which was significant after 2 days and returned to baseline on day 7 of the 14-day treatment period. 18 This antihypertensive effect could be the reason for the attenuated pressor response to Ang II and phenylephrine and the improved baroreceptor reflex function in SHR in response to long-term infusion of Ang-(1-7). 19 These effects of Ang-(1-7) are probably mediated by an enhanced synthesis and/or release of endothelial kinins, which in turn stimulate the release of the vasodilatory and cardioprotective prostaglandins 7, 20 and NO. 3, 13, 21 The presence of a unique endothelial receptor, which preferentially binds Ang-(1-7) and is distinct from Ang II subtype 1 (AT 1 ) and subtype 2 (AT 2 ) receptors, was postulated by the group of Ferrario 22 from binding experiments on bovine aortic endothelial cells (BAECs). Recent studies demonstrated that Ang-(1-7) is not only a substrate but also an endogenous inhibitor of angiotensin-converting enzyme (ACE) by binding to the active site of ACE responsible for the inactivation of bradykinin (BK). 23 Inhibition of the active site of ACE also induces "cross-talk" between ACE and BK subtype 2 (B 2 ) receptors on plasma membranes, abolishing the desensitization of the B 2 receptor. 24 This kind of interaction can explain the well-documented kinin-like actions of Ang-(1-7) observed in coronary vessels 3, 9 and in rats, [25] [26] [27] without having a direct effect on the B 2 receptor by itself. 24 The ability of Ang-(1-7) to stimulate the release of endothelial NO has been indirectly shown only by the abolishment of its vasodilatory response through removal of the endothelium or by the use of NO synthase (NOS) inhibitors. 3, 13, 28 Therefore, we directly investigated the effect of Ang-(1-7) on NO release from primary cultured BAECs via a porphyrinic microsensor placed in close proximity to the cell surface. Second, we correlated the Ang-(1-7)-induced NO release with the endothelial production of O 2 Ϫ . Last, we addressed the specificity of the Ang-(1-7)-induced NO release.
Methods

Endothelial Cell Culture
BAECs were isolated through digestion with dispase and were cultured as previously described. 29 Cells were seeded onto 6-well plates (Nunc Intermed) that were precoated with collagen R and were grown to confluence. The culture medium used for BAECs was Dulbecco's modified Eagle's/Ham's F-12 medium (1:1) that contained 1 mmol/L L-arginine, heat-inactivated FCS (20%), 50 IU/mL penicillin, 50 g/mL streptomycin, 1 mmol/L L-glutamine, 5 g/mL glutathione, and 5 g/mL L-(ϩ)-ascorbic acid. The purity of the primary cultured BAECs was characterized by uptake of fluorescent labeled LDL (DiI-Ac-LDL) and by negative staining for ␣-smooth muscle actin.
Direct NO Measurements
Primary cultures of BAECs grown to confluence in 6-well plates were used (200 to 250 g protein or 3ϫ10
Ϫ5 cells per well). 29, 30 After removal of the culture medium through aspiration, the monolayers were washed twice with 2 mL warm (37°C) HEPES-Tyrode's solution, pH 7.4, containing (in mmol/L) KCl 2.7, NaCl 137, CaCl 2 1.8, MgCl 2 2, NaH 2 PO 4 0.36, glucose 5, and HEPES 10. Thereafter, the cells were preincubated for 15 minutes at 37°C with 1 mL HEPES-Tyrode's solution containing 3-isobutyl-1-methyl-xanthine (IBMX; 100 mol/L). IBMX was added to provide identical incubation conditions as the intracellular cGMP measurements in previously reported experiments. 30 Agonists, dissolved in HEPESTyrode's solution, and superoxide dismutase (SOD; 0.3 mol/L) were added at the concentrations and times indicated in Results. The detection of NO with a porphyrinic microsensor and its preparation were performed as previously described. 31, 32 The current proportional to NO concentration was measured with the sensor, which operated in amperometric mode (EG&G PAR model 283 Potentiostats, Galvanostats) at constant potential of 0.68 V versus saturated calomel electrode.
The sensor was positioned on the surface of the cell membrane with the use of a micromanipulator, and the drugs were injected with a nanoinjector, which was positioned at close proximity (5 to 7 m) from the cell surface. The microsensor had a response time of 0.1 ms at micromolar NO concentrations and 10 ms at the detection limit of 1 nmol/L. Therefore, the sensor could detect only a concentration of NO that was not consumed by the extremely fast intracellular reaction of NO with O 2 Ϫ .
Direct O 2 ؊ Measurements
The O 2 Ϫ concentration was measured with the electrochemical sensor placed on the surface of BAECs. The sensor was prepared according to a procedure described in detail previously. 33, 34 The sensing materials were immobilized on the surface of the carbon fiber. The carbon fiber support was prepared as described for the NO sensor. The diameter of the sensor was 1 to 1.5 m, the response time was 0.05 ms, and the detection limit was 1 nmol/L. 
Chemicals
SOD (from bovine erythrocytes, specific activity 3300 U/mg) and collagen R were purchased from Serva. DiI-Ac-LDL was purchased from PaeselϩLorelei. Ang-(1-7), [D-Ala 7 ]Ang-(1-7), BK acetate salt, calcium ionophore (CaI) A23187, and N -nitro-L-arginine methyl ester (L-NAME) were purchased from Sigma Chemical Co. EXP 3174, PD 123,177, and icatibant (HOE 140) were synthesized at Aventis Pharma.
Statistical Analysis
Values are expressed as meanϮSEM from 5 experiments, with PϽ0.05 considered statistically significant. Statistical evaluation was made with ANOVA followed by unpaired Student's t test. All analyses were made with the statistical software Microcal Origin. Figure 1a shows the result of simultaneous assessment of the changes in NO and O 2 Ϫ concentrations with time after the addition of 10 mol/L Ang-(1-7). The peptide stimulated NO release with a peak concentration of 280Ϯ30 nmol/L (nϭ5), which was accompanied after a delay of 3.0Ϯ0.3 s by a very low peak O 2 Ϫ production of 18Ϯ2 nmol/L (nϭ5). The rates of NO and O 2 Ϫ increases were 120Ϯ10 and 16Ϯ3 nmol ⅐ L Ϫ1 ⅐ s Ϫ1 (each nϭ5), respectively. In comparison with Ang- (1-7) , the receptorindependent CaI A23187 and BK showed different kinetics of NO and O 2 Ϫ release (Figures 1b and 1c) . A23187 (1 mol/L) and BK (0.1 mol/L) evoked significantly higher peak NO concentrations (560Ϯ25 and 490Ϯ20 nmol/L, respectively) associated with faster rates of NO increases (650Ϯ20 and 280Ϯ30 nmol ⅐ L Ϫ1 ⅐ s
Results
Ϫ1
, respectively) than did Ang-(1-7). CaI A23187-and BK-induced peak concentrations of O 2 Ϫ were 80Ϯ6 and 32Ϯ4 nmol/L, respectively, which were significantly higher than the peak O 2 Ϫ concentrations induced by Ang-(1-7). In addition, the rates of increases in O 2 Ϫ concentrations (120Ϯ12 and 26Ϯ3 nmol ⅐ L Ϫ1 ⅐ s
, respectively) for CaI A23187 and BK were much faster than that observed for Ang-(1-7). The peak NO concentration increased with increasing concentrations of Ang-(1-7) (Figure 2 ). The observed release of NO from BAECs was in exactly the same concentration range of Ang-(1-7) as determined for the release of cGMP (unpublished data).
As shown in Figure 2 , the Ang-(1-7)-stimulated NO release from BAECs was significantly (and competitively) reduced by Ϸ60% when the cells were preincubated for 20 minutes with a 200 mol/L concentration of the NOS inhibitor L-NAME. 
Discussion
The present study demonstrated for the first time through direct measurements of NO via a porphyrinic microsensor that exogenously added Ang-(1-7) stimulated the release of the vasodilator NO from primary cultured BAECs. The Ang-(1-7)-induced NO release was concentration dependent (ED 50 Ϸ3 mol/L) and inhibited to 60% by L-NAME. This inhibition rate is in the range (60% to 70%) observed for NO release stimulated by other NOS agonists (CaI, BK, etc). 35 Ang-(1-7) is able to activate endothelial NOS, which is in line with the reported vasorelaxant effect of Ang-(1-7) on precon- tracted canine or porcine coronary arteries, which could be blocked by pretreatment with NOS inhibitors. 3, 13, 14 The presence of a unique Ang-(1-7) receptor distinct from AT 1 -(1-7) and to block some of the biological effects of Ang-(1-7) . 22, 36 However, up to now, there has been no direct evidence of the existence of a unique Ang-(1-7) receptor, and in our study on cultured BAECs, [D-Ala 7 ]Ang-(1-7) failed to completely block (50% blockade only) the NO release induced by Ang- (1-7) . Moreover, the reduction of the Ang-(1-7)-stimulated NO release by the AT 1 antagonist EXP 3174 and, even more pronounced, by the AT 2 antagonist PD 123,177 of 60% and 90%, respectively, observed in our experiments supports the view that AT 2 , but also AT 1 , receptors might be involved in the reported actions of Ang- (1-7) .
Reports that describe the effects of AT 1 and AT 2 antagonists on the Ang-(1-7)-induced functional responses are not consistent, possibly due to organ and species differences in Ang II receptor subtype specificity. Attenuation only by an AT 2 antagonist in porcine aortic smooth muscle cells 37 or only by an AT 1 antagonist in canine coronary arteries 9 or a lack of inhibition in canine coronary arteries 13 by both AT 1 and AT 2 antagonists was reported. Hence, it might be speculated that Ang-(1-7) interacts with multiple binding site on endothelial cells, all of which promote the activity of the endothelial kinin system. This hypothesis is supported by the observed complete inhibition of the Ang-(1-7)-induced NO release on BAECs by the B 2 receptor antagonist icatibant and clearly indicates that the observed NO release is correlated with an enhanced synthesis and release of endogenous kinins followed by subsequent stimulation of B 2 receptors. 38 At the present, the mechanisms by which Ang-(1-7) exerts its kinin-mediated NO release are still a matter of speculation ( Figure 4) . From experiments in canine coronary arteries that show an inhibition of the Ang-(1-7)-induced nitrite production by protease inhibitors, which block the local formation of kinins, it was suggested that the kallikrein-kinin system becomes activated via stimulation of a specific receptor for Ang-(1-7). 9 Similarly, prior findings of our group revealed that the NO release from BAECs induced by Ang II is associated with an enhanced synthesis and/or release of endogenous kinins. 8 More recent investigations demonstrated the ability of Ang-(1-7) to inhibit ACE activity with an IC 50 value of 3 and 0.65 mol/L in human plasma 17 and canine lung, 23, 28 respectively. Thus, the applied Ang-(1-7) concentrations of 1 to 10 mol/L, at which we observed an increased NO synthesis on BAECs, could have partially inhibited endothelial ACE activity. Furthermore, Ang-(1-7) has been shown to indirectly resensitize B 2 receptors via induction of a cross-talk between the B 2 receptors and ACE on plasma membranes without having a direct effect on the B 2 receptors and the BK hydrolyses. 23 Activation of the unique non-AT 1 , non-AT 2 receptor deduced from binding studies on membranes from cultured BAECs 22 is also a possible explanation for the observed stimulated synthesis and release of NO by Ang- (1-7) . However, the signal transduction pathway coupled to this putative Ang-(1-7) receptor is unknown. We found that Ang- . 39 However, very recent data indicate that there are other intracellular mechanisms that are able under certain conditions, such as, fluid shear stress and insulin, to activate endothelial NOS through phosphorylation of the enzyme at basal levels of intracellular Ca 2ϩ . 40 We could show through the simultaneous measurement of NO and O 2 Ϫ that the moderate NO release by Ang-(1-7) is associated with very low concomitant production of O 2 Ϫ . The kinetics of the Ang-(1-7)-induced NO and O 2 Ϫ release are much different than those particularly observed for CaI and BK. In comparison, the stronger NO releasers BK and CaI caused faster O 2 Ϫ production with significantly higher peak O 2 Ϫ concentrations. Consequently, our data imply that rapid NO generation is correlated to high O 2 Ϫ production. Because it has been suggested that the generation of O 2 Ϫ and subsequent fast reaction between O 2 Ϫ and NO to form peroxynitrite and cytotoxic radicals may play a role in endothelial dysfunction and vascular injury, Ang-(1-7) with its NO/O 2 Ϫ -releasing profile might be able to preserve a functional vascular system.
A rapid consumption of local L-arginine, the substrate of endothelial NOS, due to rapid NO production may be the reason for a disarrangement of NOS, which starts to produce 
O 2
Ϫ . It has been demonstrated that isolated neuronal NOS may also produce O 2 Ϫ when tetrahydrobiopterin and L-arginine are not present in sufficient amounts. 35 Moreover, dysfunctional NOS seems to be the main source of CaIstimulated O 2 Ϫ production in aortas of prehypertensive 41 and old 42 SHR. Whether the Ang-(1-7)-and BK-mediated O 2 Ϫ production is formed via a dysfunctional NOS and/or other enzymes such as xanthine oxidases and NAD(P)H-dependent oxidases remains to be elucidated.
